Insurance status can influence an individual’s ability to access care, stated Milena Murray, PharmD, MSc, BCIDP, AAHIVP, associate professor at Midwestern University College of Pharmacy.
Insured/uninsured status, region, and social determinants of health, such as lack of internet access, can all influence an individual’s ability to access care, stated Milena Murray, PharmD, MSc, BCIDP, AAHIVP, associate professor at Midwestern University College of Pharmacy, who practices at Northwestern Medicine's Infectious Disease Center in Chicago.
Transcript
How can patients newly living with HIV access necessary care resources?
That depends on if they are insured or uninsured and the region that they're located in. So for an uninsured patient, there are a lot of free clinics oftentimes and they might be surprised by finding a free clinic in their area, if it’s maybe not a large city like Chicago. Obviously, we have many free clinics, clinics [that] are available free of cost.
Patients who have insurance can start by looking for a provider within their network; oftentimes, they can see who the provider is, if they're looking for a specific type of provider. So say if it's a transgender individual and they want a clinic specializing in transgender care, they can often look for that.
There are many resources available online to find care. And so it might just be that simple online search. And then we always want to think about, again, those social determinants of health. So somebody doesn't have the internet, what can they do? And so hopefully they could go to a free library or someplace like that where they would be able to then do that internet search to find those resources.
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More